Clinical Trial Update: Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin) [Phase 3]

View source ↗

Summary

This entry reports a Phase 3 clinical trial (SiroSkin) evaluating topical sirolimus for chemoprevention of facial cutaneous squamous cell carcinomas in solid or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Topical sirolimus (sirolimus)

Snippet

Sponsor: Melanoma and Skin Cancer Trials Limited | Conditions: Solid Organ Transplant Recipients, Skin Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING